HUAKANG(SH:605077) Shang Hai Zheng Quan Bao·2025-08-21 20:17Core Viewpoint - The company plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, amounting to approximately 60.61 million yuan, based on the total share capital as of August 20, 2025 [3] Group 1: Company Overview - The company is named Zhejiang Huakang Pharmaceutical Co., Ltd. and is identified by the stock code 605077 [6] - The company has undergone changes in its governance structure, including the cancellation of the supervisory board, with its responsibilities being transferred to the audit committee of the board [14][16] Group 2: Financial Data - The company reported that its revenue is expected to increase in 2025 due to the commencement of production lines for the "1 million tons corn deep processing health food ingredient project" and the acquisition of a wholly-owned subsidiary [5] - The total number of shares has increased from 303,048,234 to 303,049,751 due to the conversion of convertible bonds, resulting in a slight increase in registered capital [15][16] Group 3: Board Meeting Resolutions - The board of directors held a meeting on August 21, 2025, where several key resolutions were passed, including the approval of the 2025 semi-annual report and the profit distribution plan [8][9] - The board also approved the proposal to cancel the supervisory board and amend the company's articles of association, which will be submitted for shareholder approval [9][10][14]